Skip to main content
Clinical Trials/ACTRN12610000376044
ACTRN12610000376044Recruiting未知

Contribution of the level of protein load and duration, to the effects of intraduodenal protein, on antropyloroduodenal motility, gut hormone release and sensations of appetite in lean and obese males.

Dr Natalie Luscombe-Marsh0 sites32 target enrollmentStarted: May 11, 2010Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
32

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to 60 Years (—)
Sex
Male

Inclusion Criteria

  • non-obese with a Body Mass Index (BMI) of 18-25kg/m2 and obese with a BMI of 27-35kg/m2
  • Weight stable (<5% fluctuation in body weight in previous 3 months)

Exclusion Criteria

  • Significant gastrointestinal symptoms, disease or surgery. Use of prescribed or non-prescribed medications (including vitamins and herbal suppliments) which may effect energy metabolism, gastrointestinal function, body weight or appetite (eg domperidone and cisapride, anticholinergic drugs (eg atropine), metoclopramide, erythromycin, hyoscine, orlistat, green tea extracts, astragalus, St Johns Wort etc)

Investigators

Sponsor
Dr Natalie Luscombe-Marsh

Similar Trials